Antibiotics in Malaria Therapy and their Effect on the Parasite Apicoplast

被引:34
作者
Pradel, G. [1 ]
Schlitzer, M. [2 ]
机构
[1] Univ Wurzburg, Res Ctr Infect Dis, D-97080 Wurzburg, Germany
[2] Univ Marburg, Dept Pharmaceut Chem, D-35032 Marburg, Germany
关键词
Malaria; Plasmodium; apicoplast; antibiotic; target; delayed death; antimalarial drug; PLASMODIUM-FALCIPARUM MALARIA; IN-VITRO ACTIVITY; PEPTIDYL-TRANSFERASE CENTER; FATTY-ACID BIOSYNTHESIS; PLASTID-LIKE ORGANELLE; GREEN ALGAL ORIGIN; ANTIMALARIAL-DRUG; VIVAX MALARIA; DOUBLE-BLIND; DELAYED DEATH;
D O I
10.2174/156652410791065273
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The impact of selected antibiotics on combating malaria infections was discovered in the mid of last century. Only recently, studies on their modes of action in malaria parasites have been initiated, prompted by the discovery of a prokaryotic organelle, the apicoplast. This plastid-derived structure, which originates from a secondary endosymbiotic event, possesses important metabolic as well as housekeeping functions, including fatty acid and heme biosynthesis. Due to its indispensability for parasite survival it represents a promising target for the use of antibiotics in malaria therapy. Most antibiotics cause a delayed death phenotype, which manifests in the late onset of antimalarial activity during the second replication cycle of the pathogen. This review will describe the effect of classical antibacterial agents against malaria parasites and the use of some of these compounds in clinical settings. Firstly we discuss the current knowledge about the physiological and morphological effects of antibiotics on the parasite and the apicoplast in particular, with special focus on the delayed death effect. Secondly antimalarial antibiotics are specified and their effects in vitro are compared with available in vivo data and clinical studies. Major precautions and side effects are described.
引用
收藏
页码:335 / 349
页数:15
相关论文
共 167 条
[1]
Akinyemi KO, 2007, J HEALTH POPUL NUTR, V25, P351
[2]
Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya [J].
Andersen, SL ;
Oloo, AJ ;
Gordon, DM ;
Ragama, OB ;
Aleman, GM ;
Berman, JD ;
Tang, DB ;
Dunne, MW ;
Shanks, GD .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :146-150
[3]
Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P-berghei in mice by combination with ciprofloxacin [J].
Andrade, Anderson Assuncao ;
de Pilla Varotti, Fernando ;
de Freitas, Isabela Oliveira ;
Nora de Souza, Marcus Vinicius ;
Alves Vasconcelos, Thatyana Rocha ;
Boechat, Nubia ;
Krettli, Antoniana Ursine .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 558 (1-3) :194-198
[4]
Thiopeptide Antibiotic Biosynthesis [J].
Arndt, Hans-Dieter ;
Schoof, Sebastian ;
Lu, Jin-Yong .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (37) :6770-6773
[5]
Artemisinin-based combinations [J].
Ashley, EA ;
White, NJ .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) :531-536
[6]
Thiopeptide antibiotics [J].
Bagley, MC ;
Dale, JW ;
Merritt, EA ;
Xiong, A .
CHEMICAL REVIEWS, 2005, 105 (02) :685-714
[7]
Neglect of Plasmodium vivax malaria [J].
Baird, J. Kevin .
TRENDS IN PARASITOLOGY, 2007, 23 (11) :533-539
[8]
Real-World Therapies and the Problem of Vivax Malaria [J].
Baird, J. Kevin .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24) :2601-2603
[9]
Resistance to Therapies for Infection by Plasmodium vivax [J].
Baird, J. Kevin .
CLINICAL MICROBIOLOGY REVIEWS, 2009, 22 (03) :508-534
[10]
Why are plastid genomes retained in non-photosynthetic organisms? [J].
Barbrook, AC ;
Howe, CJ ;
Purton, S .
TRENDS IN PLANT SCIENCE, 2006, 11 (02) :101-108